The management team of Anjiekon primarily consists of medical professionals x tech industry executives x professional marketing specialists. Our defining characteristic is being market-oriented, utilizing innovative marketing models to rapidly solve pain points, and establishing a highly integrated vertical and horizontal cross-industry ecosystem. Through an innovative business model, we lower the entry barrier for users to the lowest in the market, with the goal of becoming the nation's largest care platform for the "three highs" (hypertension, hyperglycemia, and hyperlipidemia), improving the efficacy of chronic disease control, and reducing overall healthcare expenditures.

Having served in the ICT industry for a long time, we are well aware that the Internet of Things (IoT), wearable devices, and AI smart healthcare are the major future trends of ICT, and are already in motion today. Why, then, has Taiwan or even the global market not proposed a comprehensive smart healthcare solution for the "three highs"? It is because there is no "concrete solution to pain points," "insufficient integration" across industries, and a lack of a viable "business model."

We have secured the participation and endorsement of medical professionals, who are actively involved in our development process. By collecting continuous multiple physiological signals through AIoT wearable devices and integrating medical data from the My Health Bank, we utilize artificial intelligence to develop health risk prediction systems and expert decision support systems. This enables chronic disease patients to receive personalized care, achieving the goal of "precision medicine," and thereby reducing overall healthcare expenditures for chronic diseases.
(The content above was translated by AI.)